Linezolid prescribing information details its use as an antibiotic for specific bacterial infections, including community-acquired and hospital-acquired pneumonia, and complicated skin and skin structure infections [1]. It is also indicated for certain vancomycin-resistant Enterococcus faecium infections [1].
What infections does Linezolid treat?
Linezolid is prescribed for serious infections caused by susceptible Gram-positive bacteria. These include:
* Community-acquired pneumonia and hospital-acquired pneumonia when caused by specific bacteria like Streptococcus pneumoniae, Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains), and Enterococcus faecalis [1].
* Complicated skin and skin structure infections attributed to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant strains), Streptococcus pyogenes, and Enterococcus faecalis [1].
* Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible strains only) and Streptococcus pyogenes [1].
* Vancomycin-resistant Enterococcus faecium infections, including cases with or without concurrent bacteremia [1].
How should Linezolid be administered?
Linezolid is available in oral (tablets and oral suspension) and intravenous formulations [1]. The recommended dosage and duration of treatment depend on the type and severity of the infection [1]. For adults, the typical oral dose is 600 mg every 12 hours for 10 to 14 days, and the IV dose is also 600 mg every 12 hours for 10 to 14 days [1].
What are the serious side effects of Linezolid?
Linezolid carries significant safety warnings, particularly regarding the risk of myelosuppression, which can lead to thrombocytopenia (low platelet count), anemia, and neutropenia. This risk increases with longer durations of treatment [1]. Patients receiving linezolid should have their blood counts monitored weekly, and more frequently if treatment exceeds two weeks or if they have pre-existing bone marrow suppression [1].
Another critical concern is the potential for neuropathy. Peripheral neuropathy and optic neuropathy have been reported, which may be irreversible [1]. Patients experiencing symptoms like numbness, tingling, or vision changes should discontinue linezolid and seek medical attention [1].
Linezolid also carries a black box warning for serotonin syndrome due to its monoamine oxidase (MAO) inhibitor activity [1]. This can occur when linezolid is taken with serotonergic agents, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, and opioid analgesics containing tramadol [1]. Symptoms can include confusion, agitation, hallucinations, rapid heartbeat, fever, and muscle rigidity [1].
Drug interactions with Linezolid
Due to its MAO inhibitory properties, linezolid requires caution with several types of medications:
* Serotonergic drugs: As mentioned, concurrent use with SSRIs, SNRIs, tricyclic antidepressants, triptans, and certain opioid analgesics can lead to serotonin syndrome [1].
* Adrenergic and dopaminergic agents: Linezolid may potentiate the hypertensive effects of vasopressor agents, such as pseudoephedrine and phenylephrine, as well as sympathomimetic amines [1].
* Tyramine-containing foods: Patients taking linezolid should avoid large quantities of tyramine-rich foods and beverages, as this can lead to a hypertensive crisis [1].
When does Linezolid's patent expire?
Information on specific patent expiry dates for linezolid formulations and manufacturing processes can be found on specialized databases like DrugPatentWatch.com [2]. These dates are crucial for understanding when generic versions of the drug may become available.